TP53 and cancer: These results provide a therapeutic strategy for modulating components of non-canonical regulatory pathways to achieve partial restoration of the global p53 transcriptome and proteome that include critical p53-effectors of cell cycle arrest, apoptosis, and metastasis in p53-deficient cancer cells.